ENTITY
CSL Ltd

CSL Ltd (CSL AU)

120
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bullishBlackmores Ltd
11 Oct 2017 12:39

Equity Asia Weekly Research - 11 Oct 2017

Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAPWhat's new from last week• Although ASX remains within its 3-month...

Logo
BBSP Asia
287 Views
Share
bullishCSL Ltd
10 Oct 2017 09:55

Not All Players Are Equal in the Plasma Industry

According to Allied Market Research, the IVIG (intravenous IG) market was valued at US$7.86bn and is expected to reach US$12.36bn by 2022. IVIG is...

Share
06 Sep 2017 05:08

China's Healthcare Reform Consolidates Drug Distribution and Cuts Manufacturer Margins

Rolling Out A “Two Invoices” System Nationwide:Although the announcement of a new policy to consolidate the distribution channels for both...

Logo
298 Views
Share
07 Jul 2017 15:24

Time to Look at the Laggards in Aussie Healthcare

Australian Growth stocks have under-performed in the past four years, but they generally perform well in a rising global interest rate...

Logo
414 Views
Share
06 Mar 2017 19:51

Australia's Major Banks - Look Through the Negative Sentiment

Much of the newsflow around Australia's major banks has been negative in the past year.  In addition to the prospect of a further lift in capital...

Logo
212 Views
Share
x